SICKTITTIES.org™
SICKTITTIES.ORG is an impact organization A Movement Rooted in Truth
SickTitties.org™ began as a bold statement — and has grown into a global campaign to change the future of women’s health.
Our mission is to use art, media, and technology to fund the first peer-reviewed AI clinical study focused on Breast Implant Illness (BII) and Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).. All while building NobleCare.ai, an AI healthcare platform that helps diagnose, finance, treat, and educate patients faster than ever before.
We are a collective of survivors, creators, clinicians, technologists, and advocates standing together to demand accountability, transparency, and care
Success means lowering the cost, risk, and time it takes to diagnose and treat patients suffering from Breast Implant Illness (B.I.I.) and Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
SICKTITTIES.org™
OUR STORY
SICKTITTIES.org™ founder is survivor, artist and advocate Kristin Nobles, is transforming 25 years of personal struggle into a global healthcare movement for truth and change.
After 30 surgeries, 13 years on feeding tubes, and more than 1000 days in the hospital, along with countless medical issues, Kristin finally found the cause of her 17 years of chronic illness: her breast implants were literally killing her. Misdiagnosed for years, she now faces BI-ALCL, a cancer caused by Breast Implant Illness (B.I.I.).
Kristin is a social impact producer and technologist determined to turn her crisis into an opportunity to educate, inspire, empower, and save millions of women.
For Kristin, her success is rooted in inspiring people through her story, fostering a community that can save millions of women suffering from B.I.I., and protecting future generations from this horrible and deadly illness. Her journey from personal pain to global purpose drives every aspect of SICKTITTIES.org™.
SICKTITTIES.org™
THE NUMBERS THEY DON’T TALK ABOUT
In 2021, the FDA issued a Black Box Warning for all breast implants—the strongest consumer safety alert available—mandating that patients be informed of serious risks, including Breast Implant Illness (BII) and BIA-ALCL, a rare cancer linked to textured implants. A new Full Disclosure Law now requires surgeons and manufacturers to provide clear, written risk information before surgery. Yet, despite these safeguards, implant procedures continue to rise each year. This echoes history—when Dow Corning’s implants were pulled from the market in the 1990s after widespread safety lawsuits—showing that decades later, the same warnings persist while the industry continues to expand. However the industry is still growing and procedures are increasing.
KEY STATS
3.5M
U.S. Women
With breast implants
35M
Global Women
With breast implants
365K
Augmentations
Performed in U.S. in 2023
750K
Total Surgeries
Annual procedures (incl. reconstruction)
Cancer Survivors & Reconstruction
Many cancer survivors choose implants for reconstruction, often unaware of the potential long-term health risks.In 2023, approximately 157,000 women underwent breast reconstruction following a mastectomy. A significant majority of these women opted for implants.
77%
Chose Implants
Over tissue reconstruction
This means over 120,000 cancer survivors each year receive implants, potentially exposing them to the very illnesses we are fighting to understand.
The Growing Impact
At the current growth rate, the number of women living with breast implants will exceed 4 million in the U.S. by 2026, and 40 million globally. This rapidly expanding population demands comprehensive, unbiased research.Every year, hundreds of thousands of new patients enter a system that still lacks long-term safety data and unbiased clinical research. The result: millions of women are living with pain, confusion, and medical dismissal — without a trusted source of truth.
The True Impact and Cost of Breast Implants
The Hidden Burden
For years, millions of women with Breast Implant Illness (BII) have lived without answers. Because the condition was not formally recognized until recently, most patients spend years being misdiagnosed—treated for symptoms rather than causes. This gap in awareness among both doctors and patients has created one of the most overlooked health crises in modern medicine.
The Financial Toll
Women often spend hundreds of thousands of dollars across specialists, tests, and treatments trying to identify what’s wrong. Even when the cause is known, recovery is expensive: explant surgery costs between $15,000 and $35,000 and is rarely covered by insurance.
Meanwhile, some programs still promote “implant swaps,” replacing one risky device with another—failing to address the real issue.
The Human Cost
The price of breast implants goes far beyond dollars. It’s the emotional and physical exhaustion of fighting for credibility, the loss of time, and the erosion of trust in a healthcare system that has not served these women—until now.
Through education, technology, and transparency, SickTitties.org™ and NobleCare.ai™ are building solutions that finally connect diagnosis, care, and coverage.
Key Statistics: The Overlooked Reality
Understanding the scope of Breast Implant Illness (BII) requires a look at the stark data. These U.S. statistics, aggregated from ASPS, FDA, and patient research, highlight the critical need for change in women's health. We aim to shed light on these figures and drive systemic improvements.
6-10
Years to Diagnosis
Average time before correct diagnosis of BII.
$15K-$35K
Explant Surgery Cost
Average cost, often not covered by insurance.
<10%
Insurance Coverage
Of plans covering full explant and reconstruction for illness.
25%+
Breast Cancer Survivors
Portion of implant recipients.
1 in 4
Dismissed or Misdiagnosed
Women reporting this before appropriate care.
SICKTITTIES.org™
The Solution
We’re funding the world’s first peer-reviewed clinical study and AI healthcare app designed to diagnose, finance, treat, and educate patients affected by Breast Implant Illness (B.I.I.) and BIA-ALCL.
1
Fund the Science
Every purchase helps us reach our $10 million goal to fund the science that the world has ignored for too long, driving revolutionary accountability.
2
Revolutionary Accountability
This isn't just research; it's a movement to demand real answers, backed by data and science, for those affected by breast implant issues.
3
Answers for Survivors
Over 25% of women with breast implants are breast cancer survivors, and thousands face Breast Implant Illness (BII) and BIA-ALCL. They deserve truth and support.
Our Mission
Reach 1 Million Women
SickTitties.org™ is on a mission to identify, connect, and empower 1 million women with breast implants to take back control of their health through the AI Peer-Reviewed Clinical Study and AI Healthcare App.
Diagnose
Breast Implant Illness faster and more accurately.
Finance
Affordable access to verified doctors and treatments.
Treat
Patients through data-driven, personalized care pathways.
Educate
Women and healthcare professionals with transparent data.
Every product, every dollar, every story brings us closer. 100% of profits from SickTitties.org™ merchandise, media, and events fund the Noble Care AI Clinical Study — the first peer-reviewed effort to map and manage the true impact of breast implants.
THE IMPACT GOAL
SICKTITTIES.org™
1 Million Women
Our goal is to enroll 1 million women into the SickTitties.org™ platform—creating the largest living database of women’s implant-related health data ever assembled.
1 M
Women Enrolled
The largest peer-reviewed, AI-powered breast implant safety registry, giving women a voice.
60%
Reduced Diagnostic Time & Costs
Achieved through advanced predictive modeling and early identification of BII and BIA-ALCL.
100%
Reinvested in Research
Every dollar earned is reinvested into research, care, and prevention, fueling continuous progress.
Critical Mass of Evidence
Anonymized data builds a critical mass of evidence strong enough to influence global medical policy.
AI Diagnostic & Predictive Tools
The data powers the development of AI diagnostic and predictive tools to identify early-stage illness.
Global Support & Funding
This creates a global network where survivors can access care and directly fund ongoing research.
This is more than a study—it is a movement for medical accountability and innovation.
Join the Movement
When you join the SickTitties.org™ movement, you’re not just supporting a cause — you’re building the solution.
Shop
Every shirt, hoodie, and tote from our collection funds the SickTitties.org™ x Noble Care™ Clinical Study. Your purchase directly contributes to research, technology, and patient care.
Donate
100% of donations go toward the $10 million campaign to fund the AI clinical trial, support explant patients, and accelerate NobleCare.ai™.
Partner
We’re inviting brands, healthcare innovators, sponsors, and survivors to collaborate, funding research, co-hosting events, or offering resources.
Learn
Knowledge is the first step toward prevention. Explore educational content, survivor stories, and updates from the Clinical Study.
Join us in creating the future of women’s health — where care is currency and knowledge is power.
Meet the Founders
SickTitties.org™ & NobleCare.ai™
Our leadership team combines decades of expertise in healthcare, media, technology, and finance. Each founder brings professional excellence and personal purpose to redefine women's health through innovation, transparency, and care.
Kristin Nobles
CEO & Founder
As the Founder and CEO of SickTitties.org™, Kristin Nobles has turned her personal fight for health and justice into a global movement merging art, advocacy, finance, and artificial intelligence to transform how women are diagnosed, treated, and believed.
A Silicon Valley founder with over 25 years of experience across finance, technology, and media, Kristin has led companies from early-stage growth to successful exits and built impact-driven ventures that combine profitability with purpose. She now leads the development of NobleCare.ai™, a first-of-its-kind AI healthcare and community app designed to identify, finance, and treat Breast Implant Illness (BII) and BIA-ALCL, while powering a peer-reviewed clinical study in real time.
In partnership with FIWARE.org, Kristin is architecting an ethical, open-source infrastructure that connects data, doctors, and patients securely — creating a model for transparency, access, and global collaboration. Under her leadership, SickTitties.org™ is evolving into both an impact media company and an AI-driven healthcare network. Through partnerships with iHeartMedia, FIWARE.org, and B Noble Media Group, Kristin and Christine Torres have expanded their Close to the Chest podcast into a global media movement spanning fashion, film, music, and live events to fund awareness, research, and innovation in women’s health.
Reverend Doctor Tawana Angela Davis
President & Co-Founder
Minister, scholar, and human-rights advocate, Reverend Dr. Tawana Angela Davis bridges compassion with innovation, ensuring empathy and equity are at the heart of our science.
Dr. Davis met Kristin Nobles and Christine Torres through the Close to the Chest podcast on iHeart — where shared purpose and lived experience united their voices. A breast cancer thriver who has also faced Breast Implant Illness (BII), she brings both personal insight and operational leadership to this movement.
As President and Co-Founder, Dr. Davis guides the integration of SickTitties.org™ and NobleCare.ai™, shaping them into a unified, community-driven ecosystem of care. She serves as both a voice and a conscience for the organization — reminding us daily to put the impact and EQ back into equity, and to empower people to have faith in their bodies, communities, and the science that is finally serving them.
Christine Torres
Chief Strategy Advisor & Co-Founder
Christine Torres is an award-winning producer, former Brooklyn prosecutor, and media strategist whose storytelling and investigative expertise bring both truth and accountability to the movement. With a background that spans from Law & Order to global impact campaigns, she combines her passion for justice with the discipline of fact-finding — ensuring every account we share is accurate, ethical, and rooted in lived experience.
As the Chief Strategy Advisor and Co-Founder of SickTitties.org™, Christine leads the organization’s narrative and media strategy, helping translate advocacy into global awareness through partnerships, documentaries, and multi-format media. She has been central to the development of the Close to the Chest podcast and the upcoming SickTitties Book and Medical Battery film, ensuring that each story told represents the voices, pain, and resilience of those affected by Breast Implant Illness (BII) and BIA-ALCL.
Christine’s leadership ensures that SickTitties.org™ and NobleCare.ai™ don’t just tell stories — they tell the truth. She reminds the team that justice starts with accurate storytelling and that our greatest responsibility is to the people and communities we serve.
Dirk Armbrust
Chief Financial Officer
Dirk Armbrust is the Co-Founder of the B Noble Impact Accelerator and has been part of this mission from the very beginning, working alongside Kristin Nobles to develop the financial strategy and growth plan that shaped both SickTitties.org™ and NobleCare.ai™.
An experienced M&A advisor and accelerator leader, Dirk plays a critical role in ensuring that every dollar raised translates into measurable impact. He works closely with investors, donors, partners, and internal teams to align financial sustainability with social purpose — helping transform a bold vision into a viable, scalable enterprise.
Dirk’s expertise in finance and operations has been instrumental in helping the organization not only raise capital, but also save, allocate, and multiply resources strategically. His guidance ensures that SickTitties.org™ remains both a sound business and a powerful impact opportunity, turning a movement into a long-term, self-sustaining model for change.
Dublin Wahlberg
Chief Operating Officer
Dublin Wahlberg is a writer, actor, producer, and angel investor dedicated to driving impact through storytelling, innovation, and advocacy. A passionate businessman and humanist, Dublin plays a key role in fundraising and operational strategy for SickTitties.org™ and NobleCare.ai™, helping to strengthen partnerships and expand the reach of the organization’s mission.
As an advisor and executive producer, Dublin helps curate major events, appearances, and campaigns that amplify awareness around women’s health and social justice. With a diverse creative background in media production and a lifelong interest in medicine, justice, and community empowerment, he brings both artistic insight and business discipline to the team. Dublin’s commitment to women’s health and social impact embodies the values at the heart of the organization — ensuring that every story, partnership, and project drives real-world change.
Chandra Challagonda
Chief Technology Officer
Chandra Challagonda represents the “T” in Impact — bringing world-class technology leadership to the mission of SickTitties.org™ and NobleCare.ai™. Recognized as one of the top minds in artificial intelligence, data infrastructure, and smart cloud systems, Chandra leads the design and deployment of the organization’s core technology — creating the framework that powers real-time research, financial transparency, and scalable global collaboration.
What began as a conversation with Kristin Nobles at the AI for Good event at the United Nations quickly evolved into a transformative partnership. With his leadership, experience, and access to the global FIWARE.org open-source ecosystem, Chandra has positioned NobleCare.ai™ as both a tech innovator and global impact organization — one that not only advances women’s health but also contributes to international technology standards and data ethics.
Under his leadership, SickTitties.org™ and NobleCare.ai™ are not only developing breakthrough technologies but also earning international recognition and tax credits as a global organization building next-generation healthcare infrastructure in collaboration with the top AI and SaaS data experts in the world.
United by purpose and powered by technology, our team is rewriting the story of women’s health—one breakthrough at a time.